RDGT

Ridgetech, Inc.
NASDAQHEALTHCAREPHARMACEUTICAL RETAILERS

Key Statistics

Market Cap
$2.80M
P/E Ratio
EPS
$-16.08
Beta
-0.13
52W High
$760.50
52W Low
$0.67
50-Day MA
$1.30
200-Day MA
$200.21
Dividend Yield
Profit Margin
-0.95%
Forward P/E
1.11
PEG Ratio

About Ridgetech, Inc.

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Official WebsiteUSAFY End: March

Fundamentals

Revenue (TTM)$132.16M
Gross Profit (TTM)$4.75M
EBITDA$-1.50M
Operating Margin-2.58%
Return on Equity-3.55%
Return on Assets-1.75%
Revenue/Share (TTM)$1818.73
Book Value$45.96
Price-to-Book0.07
Price-to-Sales (TTM)0.02
EV/Revenue1.587
EV/EBITDA233.06
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)21.40%
Shares Outstanding$3.63M
Float$3.61M
% Insiders0.41%
% Institutions3.79%

Historical Volatility

HV 10-Day
101.66%
HV 20-Day
133.73%
HV 30-Day
156.55%
HV 60-Day
144.59%
HV Rank

Volatility is currently contracting

Latest News

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results

HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2026. Mr. Frank Zhao, Interim Chief Executive Officer and Chief Financial Officer of Ridgetech, commented, "Fiscal year 2026 marked a transformative year for Ridgetech as we completed our strategic transition to a wholesale-focused business model.

PRNewsWire7/31/2026Neutral
Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association

HANGZHOU, China, July 24, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that its wholly owned offline pharmaceutical wholesale distribution platform, Zhejiang Jiuxin Medicine Co., Ltd. ("Jiuxin Medicine"), has been elected as a vice-president unit of the Hangzhou Qiantang District Biomedical and Cosmetic High-Quality Development Association (the "Association"), which is scheduled to be officially inaugurated on July 28, 2026.

PRNewsWire7/24/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on RDGT and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026